OMAHA, Neb.--(BUSINESS WIRE)--The Investor Movement Index ® (IMX SM) ended its five month decline in February, reaching 4.59, which is up 7.2 percent from January’s score of 4.28. The IMX is TD ...
CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today announced that the Intelligent Medicine Exchange (“IMX”), the first futures and ...
IMX-110 + Beigene/Novartis anti-PD-1 Tislelizumab combination designed to enhance response to solid tumors by turning immunologically “cold” tumors “hot” Initial data anticipated in 1H 2023 “We are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results